Li WY - Search Results

1

Clinical significance of miR-9-5p in NSCLC and its relationship with smoking.

Zhang TX, Duan XC, Cui Y, Zhang Y, Gu M, Wang ZY, Li WY. Zhang TX, et al. Among authors: li wy. Front Oncol. 2024 Apr 2;14:1376502. doi: 10.3389/fonc.2024.1376502. eCollection 2024. Front Oncol. 2024. PMID: 38628672 Free PMC article.

2

Polymorphisms in GSTM1, CYP1A1, CYP2E1, and CYP2D6 are associated with susceptibility and chemotherapy response in non-small-cell lung cancer patients.

Li W, Yue W, Zhang L, Zhao X, Ma L, Yang X, Zhang C, Wang Y, Gu M. Li W, et al. Lung. 2012 Feb;190(1):91-8. doi: 10.1007/s00408-011-9338-8. Epub 2011 Nov 23. Lung. 2012. PMID: 22109568

3

Cyclooxygenase-2 is associated with malignant phenotypes in human lung cancer.

Li W, Yue W, Wang H, Lai B, Yang X, Zhang C, Wang Y, Gu M. Li W, et al. Oncol Lett. 2016 Nov;12(5):3836-3844. doi: 10.3892/ol.2016.5207. Epub 2016 Sep 29. Oncol Lett. 2016. PMID: 27895738 Free PMC article.

4

Loss of EGFR confers acquired resistance to AZD9291 in an EGFR-mutant non-small cell lung cancer cell line with an epithelial-mesenchymal transition phenotype.

Xu J, Zhao X, He D, Wang J, Li W, Liu Y, Ma L, Jiang M, Teng Y, Wang Z, Gu M, Wu J, Wang Y, Yue W, Zhang S. Xu J, et al. J Cancer Res Clin Oncol. 2018 Aug;144(8):1413-1422. doi: 10.1007/s00432-018-2668-7. Epub 2018 May 24. J Cancer Res Clin Oncol. 2018. PMID: 29797219

5

Comparison between NOD/SCID mice and BALB/c mice for patient-derived tumor xenografts model of non-small-cell lung cancer.

Wu J, Zhang J, Jiang M, Zhang T, Wang Y, Wang Z, Miao Y, Wang Z, Li W. Wu J, et al. Cancer Manag Res. 2018 Dec 6;10:6695-6703. doi: 10.2147/CMAR.S181272. eCollection 2018. Cancer Manag Res. 2018. PMID: 30584364 Free PMC article.

6

Establishing a detection method for CCNY: a potentially significant clinical investigative marker in NSCLC patients.

Ma L, Gu M, Teng Y, Li W. Ma L, et al. Onco Targets Ther. 2019 Jan 29;12:921-932. doi: 10.2147/OTT.S180507. eCollection 2019. Onco Targets Ther. 2019. PMID: 30774378 Free PMC article.

7

Abnormally localized DLK1 interacts with NCOR1 in non-small cell lung cancer cell nuclear.

Tan J, Zhang S, Li L, Mu J, Wang Z, Zhang L, Jiang M, Li W, Yang X, Liu Y, Gao Y. Tan J, et al. Biosci Rep. 2019 Dec 20;39(12):BSR20192362. doi: 10.1042/BSR20192362. Biosci Rep. 2019. PMID: 31661545 Free PMC article.

8

PD-L1⁺ aneuploid circulating tumor endothelial cells (CTECs) exhibit resistance to the checkpoint blockade immunotherapy in advanced NSCLC patients.

Zhang L, Zhang X, Liu Y, Zhang T, Wang Z, Gu M, Li Y, Wang DD, Li W, Lin PP. Zhang L, et al. Cancer Lett. 2020 Jan 28;469:355-366. doi: 10.1016/j.canlet.2019.10.041. Epub 2019 Oct 31. Cancer Lett. 2020. PMID: 31678168 Free article.

9

Clinical Significance of miR-183-3p and miR-182-5p in NSCLC and Their Correlation.

Zhang T, Li W, Gu M, Wang Z, Zhou S, Hao X, Li W, Xu S. Zhang T, et al. Cancer Manag Res. 2021 Apr 28;13:3539-3550. doi: 10.2147/CMAR.S305179. eCollection 2021. Cancer Manag Res. 2021. PMID: 33953608 Free PMC article.

10

Combined application of bevacizumab and PD-1 blockade displays durable treatment effects by increasing the infiltration and cytotoxic function of CD8⁺ T cells in lung cancer.

Liu Y, Zhang T, Zhang L, Zhao C, Zhang Z, Wang Z, Gu M, Li W, Li B. Liu Y, et al. Immunotherapy. 2022 Jun;14(9):695-708. doi: 10.2217/imt-2021-0196. Epub 2022 May 16. Immunotherapy. 2022. PMID: 35574588 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,213 results

Search Page

Filters